Ottavia Prunas

Argante, L., Prunas, O., Medini, D., & Ypma, E. (2024). Modeling the persistence of 4CMenB vaccine protection against real world meningococcal B disease in adolescents. Npj Vaccines, 9(1). https://doi.org/10.1038/s41541-024-01025-5

Prunas, O., Shioda, K., Toscano, C. M., Bastias, M., Valenzuela-Bravo, M. T., Tito, J. D., Warren, J. L., Weinberger, D. M., & De Oliveira, L. H. (2024). Estimated Population-Level Impact of Pneumococcal Conjugate Vaccines Against All-Cause Pneumonia Mortality Among Unvaccinated in 5 Latin American Countries. Journal of Infectious Diseases, 230(4), e768–e776. https://doi.org/10.1093/infdis/jiae144

Prunas, O., Willemsen, J., Warren, J.L., Bont, L., Schwartz, J.L., Atwell, J., Begier, E., Dean, N., Hirsch, I., Karron, R., Klugman, K., Kramer, R., Leidman, E., Link-Gelles, R., Nair, H., Panozzo, CA., Pelfrene, E., Simões, E.A.F., Smith, P.G., et al. (2024). Workshop on the design and use of clinical trials with multiple endpoints, with a focus on prevention of RSV. Vaccine: X, 19. https://doi.org/10.1016/j.jvacx.2024.100509

Prunas, O., Willemsen, J. E., Bont, L., Pitzer, V. E., Warren, J. L., & Weinberger, D. M. (2024). Incorporating Data from Multiple Endpoints in the Analysis of Clinical Trials: Example from RSV Vaccines. Epidemiology, 35(1), 103–112. https://doi.org/10.1097/EDE.0000000000001680

Prunas, O., Weinberger, D. M., Pitzer, V. E., Gazit, S., & Patalon, T. (2023). Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel. Clinical Infectious Diseases, 76(1), 113–118. https://doi.org/10.1093/cid/ciac315

Prunas, O., Weinberger, D. M., Medini, D., Tizzoni, M., & Argante, L. (2022). Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls. American Journal of Epidemiology, 191(4), 724–734. https://doi.org/10.1093/aje/kwab266

Prunas, O., Warren, J. L., Crawford, F. W., Gazit, S., Patalon, T., Weinberger, D. M., & Pitzer, V. E. (2022). Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel. Science, 375(6585), 1151–1154. https://doi.org/10.1126/science.abl4292

Patalon, T., Gazit, S., Pitzer, V. E., Prunas, O., Warren, J. L., & Weinberger, D. M. (2022). Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine. JAMA Internal Medicine, 182(2), 179–184. https://doi.org/10.1001/jamainternmed.2021.7382

Warren, J. L., Prunas, O., Paltiel, A. D., Thornhill, T., & Gonsalves, G. S. (2024). Integrating testing volume into bandit algorithms for infectious disease surveillance [Journal-article]. Journal of the Royal Statistical Society Series A: Statistics in Society. https://doi.org/10.1093/jrsssa/qnae090

Prunas, O., Tiu, A., Bansal, S., & Weinberger, D. M. (2023). Evaluating the Association between Routine Pneumococcal Vaccination and COVID-19 Severity among Older Adults in the United States [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.12.27.23300578

Prunas, O., Shioda, K., Toscano, C. M., Bastias, M., Valenzuela-Bravo, M. T., Diaz Tito, J., Warren, J. L., Weinberger, D. M., & de Oliveira, L. H. (2023). Estimated population-level impact of pneumococcal conjugate vaccines against all-cause pneumonia mortality among unvaccinated age groups in five Latin American countries [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.08.08.23293814

Prunas, O., Weinberger, D. M., Pitzer, V. E., Gazit, S., & Patalon, T. (2022). Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2022.01.04.22268776